| Reversible promoter demethylation of PDGFD confers gemcitabine resistance through STAT3 activation and RRM1 upregulation L Qin, Z Dong, C Huang, H Liu, J Beebe, B Subramaniyan, Y Hao, Y Liu, ... Cancer Letters 567, 216266, 2023 | 13 | 2023 |
| A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells R Peery, Q Cui, K Kyei-Baffour, S Josephraj, C Huang, Z Dong, M Dai, ... Bioorganic & medicinal chemistry 65, 116761, 2022 | 12 | 2022 |
| Small Molecule Inhibitors Targeting the “Undruggable” Survivin: The Past, Present, and Future from a Medicinal Chemist’s Perspective Q Cui, C Huang, JY Liu, JT Zhang Journal of Medicinal Chemistry 66 (24), 16515-16545, 2023 | 7 | 2023 |
| Therapeutic activity of the lansoprazole metabolite 5-hydroxy lansoprazole sulfide in triple-negative breast cancer by inhibiting the enoyl reductase of fatty acid synthase J Beebe, S Josephraj, CJ Wang, J Danielson, Q Cui, C Huang, L Barlow, ... Journal of Medicinal Chemistry 65 (20), 13681-13691, 2022 | 7 | 2022 |
